(Q53272669)

12 May 2018

title

Post-treatment [¹⁸F]FDG maximum standardized uptake value as a prognostic marker of recurrence in endometrial carcinoma. (English)

1 reference

12 May 2018

author

Jae-Weon Kim

2

1 reference

12 May 2018

June-Key Chung

6

object named as

June-Key Chung

1 reference

12 May 2018

author name string

Hyun Hoon Chung

1

1 reference

12 May 2018

Keon Wook Kang

3

1 reference

12 May 2018

Noh-Hyun Park

4

1 reference

12 May 2018

Yong-Sang Song

5

1 reference

12 May 2018

Soon-Beom Kang

7

1 reference

12 May 2018

publication date

14 September 2010

1 reference

12 May 2018

number of pages

7

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

12 May 2018

volume

38

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

74-80

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s00259-010-1614-y

exact match

0 references

cites work

Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.

1 reference

12 December 2020

Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma.

1 reference

12 December 2020

Combined PET/CT Imaging in Oncology. Impact on Patient Management

1 reference

12 December 2020

Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer

1 reference

12 December 2020

18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression

1 reference

12 December 2020

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

1 reference

12 December 2020

18F-FDG PET in the management of endometrial cancer.

1 reference

12 December 2020

Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome

1 reference

12 December 2020

Image analysis in patients with cancer studied with a combined PET and CT scanner

1 reference

12 December 2020

Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer

1 reference

12 December 2020

The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings

1 reference

12 December 2020

Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer.

1 reference

12 December 2020

Clinical applications of PET in oncology

1 reference

12 December 2020

Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium

1 reference

12 December 2020

Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review

1 reference

12 December 2020

Hypoxia--a key regulatory factor in tumour growth

1 reference

12 December 2020

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

1 reference

12 December 2020

Determination of a normal level of serum CA125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma

1 reference

12 December 2020

The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer

1 reference

12 December 2020

Endometrial carcinoma

1 reference

12 December 2020

Correlation between clinical and histopathologic risk factors and lymph node metastases in early endometrial cancer (a multivariate analysis of 183 cases)

1 reference

12 December 2020

Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis.

1 reference

12 December 2020

Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT.

1 reference

12 December 2020

Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence.

1 reference

12 December 2020

18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases.

1 reference

12 December 2020

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

12 December 2020

Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings.

1 reference

12 December 2020

Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses

1 reference

12 December 2020

Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery

1 reference

12 December 2020

Cancer statistics, 2007

1 reference

12 December 2020

Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas

1 reference

12 December 2020

10.1007/S00259-010-1614-Y

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018